This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Managing the Agitated Psychotic Patient: A Reappraisal of the Evidence

Michael H. Allen, MD

Published: December 30, 2000

Article Abstract

Under intense public pressure, regulatory agencies have recently defined circumstances in whichmedications will be considered a form of restraint, so-called “chemical restraint.” This article proposesthat the emergency management of the agitated patient be viewed as a brief departure from theusual physician-patient collaboration. Viewed in this way, the goal is simply to terminate the emergencyin the manner most likely to be acceptable to patients and conducive to a more typical dialogue.To that end, the author reviews all controlled studies of medication treatment of agitation that haveappeared in English since the advent of the neuroleptic medications. Issues of diagnosis, relative efficacy,dosage, route, onset, offset, safety, tolerability, and consumer preference are considered.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: